N@N

Market Maker Surveillance Report. TMNG, ACHN, TKECF, IPGP, PWRD, OMER, Winning Stocks With Lowest Price Friction For Tuesday,

January 10, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3548 companies with "abnormal" market making, 4402 companies with positive Friction Factors and 1872 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. MANAGEMENT NETWORK GROUP INC (NASDAQ:TMNG), ACHILLION PHARMACEUTICALS (NASDAQ:ACHN), TOKYO ELECTRIC POWER CO INC (OTC:TKECF), IPG Photonics Corp (NASDAQ:IPGP), PERFECT WORLD CO-SPON ADR (NASDAQ:PWRD), OMEROS CORP (NASDAQ:OMER). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     TMNG       $0.390       25.32%       32,553          55.43%       26,177          44.57%       6,376           163     
     ACHN       $2.270       23.35%       3,502,320       51.46%       3,149,918       46.28%       352,402         1,552   
     TKECF      $0.470       21.86%       94,290          62.85%       32,374          21.58%       61,916          1,317   
     IPGP       $7.760       19.69%       1,545,127       50.69%       1,364,028       44.75%       181,099         233     
     PWRD       $1.720       19.52%       3,431,633       60.75%       2,165,112       38.33%       1,266,521       7,363   
     OMER       $1.020       22.82%       138,690         55.74%       110,127         44.26%       28,563          280     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows TMNG with a dollar gain Tuesday of $0.39000 and a Friction Factor of 163 shares. That means that it only took 163 more shares of buying than selling to move TMNG higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

MANAGEMENT NETWORK GROUP INC (NASDAQ:TMNG) - The Management Network Group, Inc., a management consulting company, provides professional services to the converging communications, media and entertainment industries, and the capital formation firms in the United States, the United Kingdom, and western Europe. It offers strategy and business case development services, including business case development, data and content strategies, marketing spending optimization, service and brand diversification, enterprise and small business strategies, technology commercialization, and operational strategies; knowledge management solutions to solve problems associated with knowledge creation and distribution, sharing and leveraging existing knowledge, tools, and processes. The company also provides a suite of revenue assurance assessment tools to include Ascertain, a scalable and configurable revenue management and data integrity toolset that provides evaluation of processes, metrics, and control points. In addition, it offers program management services; and integrated business and operational processes, supporting technology systems, and Web-centric interfaces in various OSS/BSS applications, as well as provides corporate investment services, including evaluation of management teams and business plans, identification of strengths and weakness of the company, and analyses of the companys financial models, systems, products, and operational and business processes. Further, the company provides technical consultancy and software development services for the communications industry, including defining requirements; data analysis; selecting and implementing mediation; provisioning, billing, and inter-operator billing products; interfacing products within a legacy environment; migrating products; data and customers; and planning, managing, and completing systems and software testing, as well as offers marketing services. The Management Network Group, Inc. was founded in 1990 and is based in Overland Park, Kansas.

ACHILLION PHARMACEUTICALS (NASDAQ:ACHN) - Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidate pipeline includes ACH-1625, a protease inhibitor, which is in phase 1/b clinical trials for the treatment of chronic hepatitis C infections; ACH-1095, a NS4A antagonist that is in late-stage preclinical studies for the treatment of chronic hepatitis C infections; and ACH-2684, a protease inhibitor, which is in late stage preclinical testing. The companys other product candidates comprise ACH-702, which is in preclinical stage for the treatment of serious bacterial infections; and Elvucitabine that is in phase II clinical trials for the treatment of HIV infection. The company has a collaboration arrangement with Gilead Sciences, Inc. to develop and commercialize compounds for the treatment of chronic hepatitis C, which inhibit viral replication through a mechanism of action. Achillion Pharmaceuticals, Inc. was founded in 1998 and is based in New Haven, Connecticut.

TOKYO ELECTRIC POWER CO INC (OTC:TKECF) - The Tokyo Electric Power Company, Incorporated engages in the generation and supply of electric power in Japan. It operates through five segments: Electric Power, Information and Telecommunication, Energy and Environment, Living Environment and Lifestyle-Related, and Overseas. The Electric Power segment engages in the supply of electricity. The Information and Communications segment involves in the telecommunication, computerized information processing, computer software development and maintenance, and cable television broadcasting businesses; and engages in the installation, site leasing, maintenance, management, and operation of computer, telecommunication, and other equipment. The Energy and Environmental segment engages in the gas supply, services related to energy facilities, maintenance and repair of power generation and other facilities, operation and maintenance of environmental protection and other facilities, design and maintenance of distribution facilities, sale of crude oil and petroleum products, repair and adjustment of electricity meters, heat supply, and cargo and vehicle transportation services, as well as in the maintenance of transmission, transformation, and other facilities. The Living Environment and Lifestyle-Related segment engages in the leasing and management of real estate, as well as in the operation and management of exhibition pavilions and show rooms. The Overseas segment provides consulting services; and engages in the power generation business. The company was founded in 1951 and is headquartered in Tokyo, Japan.

IPG Photonics Corp (NASDAQ:IPGP) - IPG Photonics Corporation manufactures fiber lasers and amplifiers for use in a range of markets, such as materials processing, advanced technologies, telecommunications, and medical applications. The company offers optical fiber-based lasers, which combine the advantages of semiconductor diodes with the high amplification and precise beam qualities of specialty optical fibers. It also provides packaged diodes, direct diode laser systems, and communications systems that utilize its optical fiber-based products. Its fiber lasers are used in materials processing applications, such as marking, printing, welding, cutting, micromachining, surface treatment, drilling, soldering, annealing, rapid prototyping, and laser-assisted machining. The companys fiber lasers and amplifiers are utilized by commercial firms, and academic and government institutions for manufacturing commercial systems and for research in advanced technologies and products. In addition, IPG Photonics Corporation designs and manufactures a DWDM transport system, a range of fiber amplifiers, and Raman pump lasers that enhance data transmission in broadband access and DWDM optical networks. The companys commercial fiber and diode lasers are incorporated into medical laser systems that are used in skin rejuvenation, skin resurfacing, and stretch mark removal applications; and diode lasers are used in dental, skin tightening, and fat melting procedures, as well as in prostate surgery. IPG Photonics Corporation sells its products to original equipment manufacturers, system integrators, and end users through direct sales force, as well as through agreements with independent sales representatives and distributors worldwide. The company was founded in 1990 and is headquartered in Oxford, Massachusetts.

PERFECT WORLD CO-SPON ADR (NASDAQ:PWRD) - Perfect World Co., Ltd., through its subsidiaries, engages in the research, development, operation, and licensing of online games primarily in the Peoples Republic of China, the United States, and the Rest of Asia. It develops online games based on its game engines and game development platforms. The companys 3D massively multiplayer online role playing games (MMORPGs) include Perfect World, an adventure and fantasy game with traditional Chinese settings; Legend of Martial Arts, an adventure story of Chinese swordsmen set in an ancient kingdom; and Perfect World II, which is set in a similar content and graphic background as Perfect World. It also offers Zhu Xian that is based on martial arts focused adventure set in a fantasy world; Chi Bi, a war story developed based on ancient Chinese history known as the Three Kingdoms; Hot Dance Party, a 3D online casual game; Pocketpet Journey West, a 3D MMORPG based on the classical novel of Chinese literature, Journey to the West; Battle of the Immortals, a mysterious adventure, which enables game players to travel between eastern and western cultures, and adventures in historic sites and turf wars; and Fantasy Zhu Xian, a 2D turn-based MMORPG based on the Internet fantasy novel Zhu Xian. It also involves in the production and distribution of films, as well as television advertising activities. The company was founded in 2004 and is based in Beijing, the Peoples Republic of China.

OMEROS CORP (NASDAQ:OMER) - Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products focused on inflammation and disorders of the central nervous system. Its product candidates are derived from its proprietary PharmacoSurgery platform that is designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological, and other surgical and medical procedures. The companys lead PharmacoSurgery product candidate, OMS103HP, is in Phase III clinical program for evaluating OMS103HPs safety and ability to improve postoperative joint function and reduce pain following arthroscopic anterior cruciate ligament; and to reduce pain and improve postoperative joint function following arthroscopic meniscectomy surgery. Its PharmacoSurgery product candidates also include OMS302, which completed its Phase I/II clinical trial for use during ophthalmological procedures; and OMS201, which is in Phase I/II clinical trial for use during urological surgery. The company also engages in developing proprietary compositions that include peroxisome proliferator-activated receptor gamma (PPARγ) agonists for the treatment and prevention of addiction to substances of abuse. Its pipeline of preclinical product development programs include MASP-2 program for developing proprietary mannan-binding lectin-associated serine protease-2 antibody therapies to treat disorders caused by complement-activated inflammation; PDE10 program for developing proprietary compounds to treat schizophrenia and other psychotic disorders; PDE7 program for developing proprietary compounds to treat movement disorders; and GPCR program for the de-orphanization of orphan G protein-coupled receptors. Omeros Corporation was founded in 1994 and is based in Seattle, Washington.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net